BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17991485)

  • 1. PIAS proteins as repressors of Oct4 function.
    Tolkunova E; Malashicheva A; Parfenov VN; Sustmann C; Grosschedl R; Tomilin A
    J Mol Biol; 2007 Dec; 374(5):1200-12. PubMed ID: 17991485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of karyopherin-alpha 2 as an Oct4 associated protein.
    Li X; Sun L; Jin Y
    J Genet Genomics; 2008 Dec; 35(12):723-8. PubMed ID: 19103427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIAS proteins are involved in the SUMO-1 modification, intracellular translocation and transcriptional repressive activity of RET finger protein.
    Matsuura T; Shimono Y; Kawai K; Murakami H; Urano T; Niwa Y; Goto H; Takahashi M
    Exp Cell Res; 2005 Aug; 308(1):65-77. PubMed ID: 15907835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of human OCT4 transactivation domains for self-regulatory transcription.
    Lim HY; Do HJ; Lee WY; Kim DK; Seo HG; Chung HJ; Park JK; Chang WK; Kim JH; Kim JH
    Biochem Biophys Res Commun; 2009 Jul; 385(2):148-53. PubMed ID: 19445899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.
    Wang J; Sun Z; Zhang Z; Saadi I; Wang J; Li X; Gao S; Engle JJ; Kuburas A; Fu X; Yu W; Klein WH; Russo AF; Amendt BA
    J Biol Chem; 2013 May; 288(18):12580-95. PubMed ID: 23515314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of RORalpha potentiates transcriptional activation function.
    Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
    Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
    Liedtke S; Stephan M; Kögler G
    Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation.
    Tahk S; Liu B; Chernishof V; Wong KA; Wu H; Shuai K
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11643-8. PubMed ID: 17606919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of transducible versions of transcription factors Oct4 and Sox2.
    Bosnali M; Edenhofer F
    Biol Chem; 2008 Jul; 389(7):851-61. PubMed ID: 18681826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIAS1 interacts with and represses SOX9 transactivation activity.
    Oh HJ; Kido T; Lau YF
    Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of protein inhibitor of activated STAT (PIAS) proteins with the TATA-binding protein, TBP.
    Prigge JR; Schmidt EE
    J Biol Chem; 2006 May; 281(18):12260-9. PubMed ID: 16522640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction of AIRE with PIAS1 in transcriptional regulation.
    Ilmarinen T; Kangas H; Kytömaa T; Eskelin P; Saharinen J; Seeler JS; Tanhuanpää K; Chan FY; Slattery RM; Alakurtti K; Palvimo JJ; Ulmanen I
    Mol Immunol; 2008 Apr; 45(7):1847-62. PubMed ID: 18083234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
    Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
    Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of OCT4 expression in somatic tumor cell lines.
    Cantz T; Key G; Bleidissel M; Gentile L; Han DW; Brenne A; Schöler HR
    Stem Cells; 2008 Mar; 26(3):692-7. PubMed ID: 18032701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumoylation differentially regulates Goosecoid-mediated transcriptional repression.
    Izzi L; Narimatsu M; Attisano L
    Exp Cell Res; 2008 Apr; 314(7):1585-94. PubMed ID: 18336814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development.
    Monk M; Hitchins M; Hawes S
    Mol Hum Reprod; 2008 Jun; 14(6):347-55. PubMed ID: 18467432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation.
    Ding X; Luo C; Zhou J; Zhong Y; Hu X; Zhou F; Ren K; Gan L; He A; Zhu J; Gao X; Zhang J
    J Cell Biochem; 2009 Feb; 106(2):285-95. PubMed ID: 19115315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gene-activation pathways by PIAS proteins in the immune system.
    Shuai K; Liu B
    Nat Rev Immunol; 2005 Aug; 5(8):593-605. PubMed ID: 16056253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling.
    Imoto S; Ohbayashi N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
    Biochem Biophys Res Commun; 2008 May; 370(2):359-65. PubMed ID: 18384750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.